Penicillin Resistant Pneumococcus

Aka: Penicillin Resistant Pneumococcus, PRP, Streptococcus Pneumoniae Antibiotic Resistance, Drug Resistant Pneumococci, DRSP

advertisement

II. Epidemiology

  1. Very serious problem
    1. Pneumococcus infection is common
    2. Otitis Media
    3. Meningitis
  2. Treatment failures common especially in Meningitis
  3. Hot spots of resistance
    1. International
      1. Spain
      2. Hungary
      3. South Africa
    2. United States
      1. Dallas
      2. Memphis
      3. Kansas City
      4. Oklahoma City
  4. High Risk Groups (New York, 1995, n=282)
    1. Children under age 4 (7.5 cases per 100,000)
    2. Children under age 1 (30.3 cases per 100,000)
    3. Adults with Human Immunodeficiency Virus (HIV)
    4. Reference
      1. (1997) MMWR Morb Mortal Wkly Rep, 46:297-9 [PubMed]
  5. Day Care Prevalence (multiple U.S. state evaluation)
    1. Nasopharyngeal and middle ear swab: 22-29% PRP
  6. Hospital Prevalence (Minneapolis, MN)
    1. Community Hospitals: 15-22% PRP
    2. Tertiary Care Hospital: 50% PRP
  7. Streptococcus Pneumoniae Resistance Rates (2003)
    1. Highest resistance (19-30%)
      1. Penicillin (21%)
      2. Cephalosporins: Cefprozil, Cefuroxime (23-25%)
      3. Macrolides: All are high resistance (23-28%)
      4. Tetracycline (19%)
      5. Trimethoprim-Sulfamethoxazole (30%)
    2. Lowest resistance rates (<10%)
      1. Amoxicillin-Clavulanate (4%)
      2. Cefepime (<1%)
      3. Ceftriaxone (2%)
      4. Fluoroquinolones: Levaquin, Avelox (<1%)
      5. Clindamycin (9%)
      6. Vancomycin (0%)
    3. References
      1. Jones (2003) Diagn Microbiol Infect Dis 46:77-80 [PubMed]

III. Risk Factors

  1. Age over 65 years (Odds Ratio 3.8)
  2. Within last 3 months, beta-lactam Antibiotic - Penicillins, Cephalosporins, Carbapenems, and Monobactams (Odds Ratio 2.8)
  3. Alcohol Abuse (Odds Ratio 5.2)
  4. Immunosuppression
  5. Multiple comorbid medical conditions
  6. Exposure to day-care attending children
  7. Reference
    1. Fraboni (2012) Board Review Express, San Jose

IV. Management: Pneumonia or Sepsis

  1. Intermediate Resistance
    1. Higher Penicillin dosage: 150k-250k U/kg/day
  2. High Resistance
    1. Three drug Combination regimen
      1. Vancomycin (40 mg/kg/day) and
      2. Imipenem and
      3. Rifampin
    2. Two drug combination regimen
      1. Vancomycin
      2. Third Generation Cephalosporin (if not resistant)

V. Management: Meningitis

  1. Intermediate Resistance
    1. Vancomycin (60 mg/kg/day) and
    2. Imipenem
  2. High resistance
    1. Vancomycin (60 mg/kg/day) and
    2. Rifampin and
    3. Imipenem
  3. Follow-Up Spinal Tap in 24 hours

VI. Management: Otitis Media

  1. Intermediate Resistance
    1. Amoxicillin (75 mg/kg/d)
    2. Clindamycin
      1. No coverage for HaemophilusInfluenzae
      2. No coverage for Moraxella catarrhalis
    3. Cefuroxime
    4. Cefprozil
    5. Cefpodoxime
  2. High Resistance
    1. Base on Tympanocentesis culture

VII. Prevention

  1. Pneumococcal Vaccine
    1. Public Health may add to 2 year old Immunizations
    2. Would create Herd Immunity to some pneumococcus

Images: Related links to external sites (from Bing)

These images are a random sampling from a Bing search on the term "Penicillin Resistant Pneumococcus." Click on the image (or right click) to open the source website in a new browser window. Search Bing for all related images

Related Studies

Related Topics in Emerging Infections

advertisement